1. Home
  2. DHIL vs NBY Comparison

DHIL vs NBY Comparison

Compare DHIL & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diamond Hill Investment Group Inc.

DHIL

Diamond Hill Investment Group Inc.

HOLD

Current Price

$172.81

Market Cap

463.8M

Sector

Finance

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.38

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHIL
NBY
Founded
1990
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
463.8M
31.6M
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
DHIL
NBY
Price
$172.81
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.5K
917.6K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
3.47%
N/A
EPS Growth
14.37
35.42
EPS
17.91
0.76
Revenue
$145,201,729.00
$370,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
N/A
$32.05
P/E Ratio
$9.67
$1.87
Revenue Growth
6.69
N/A
52 Week Low
$114.11
$0.43
52 Week High
$173.70
$19.95

Technical Indicators

Market Signals
Indicator
DHIL
NBY
Relative Strength Index (RSI) 65.08 44.53
Support Level $170.59 $0.99
Resistance Level N/A $1.36
Average True Range (ATR) 0.81 0.22
MACD -0.09 0.15
Stochastic Oscillator 74.52 32.73

Price Performance

Historical Comparison
DHIL
NBY

About DHIL Diamond Hill Investment Group Inc.

Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: